|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 6,2000 PSA#2573National Institutes of Health, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, Natcher Building, Room 5AS-13A, 45
Center Drive, MSC 6500, Bethesda, Maryland 20892-6500 A -- NEW RESEARCH REGISTRIES FOR THE NATIONAL INSTITUTE OF ARTHRITIS
AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) SOL NIH-NIAMS-00-02 DUE
060900 POC Erin Lange, 301/594-2543 WEB:
http://www.nih.gov/niams/grants/rfp/rfplist.htm,
http://www.nih.gov/niams/grants/rfp/rfplist.htm. E-MAIL:
langee@mail.nih.gov, langee@mail.nih.gov. This is an announcement of
the availability of a Broad Agency Announcement which describes in
general terms research topics and outlines proposal preparation
requirements. The work requirements are developed and defined by the
offeror and not the Government. The National Institute of Arthritis and
Musculoskeletal and Skin Diseases (NIAMS), National Institutes of
Health (NIH), is seeking contractors to support the collection of
demographic and clinical data from patients, families and appropriate
control cases of rare, heritable and non-heritable diseases or
conditions, or informative subsets of common diseases, particularly in
those instances where no available registry now exists. The
information to be collected for the Registry would be that sufficient
to establish the diagnosis of the disease and relevant information
required to subserve defined research purposes. Limited collection of
patient materials for research purposes (blood sample/DNA) will be
allowed as part of the Registry's functions. Forthis acquisition the
NIAMS is interested in rare heritable and non-heritable diseases and
informative subsets of more common disease. These diseases are listed
on the NIAMS web site http://www.nih.gov/niams/grants/ep2.htm under
"NIAMS Extramural Research Program, Areas of Special Interest."
Overall, the goal of the Registry would be to collect sufficient
information on individuals and/or families with the specific disease(s)
or groups of related diseases or conditions, or disease subsets to
allow Investigators interested in studying those diseases to use the
Registry data to assist them in obtaining sufficient numbers of
patients to pursue their research objectives. The specific objectives
would vary depending upon the disease or condition in question and the
basic research or clinical research to be supported by the Registry,
but they will be within the following categories: (1) Technical
Objective A is to design and implement a Research Registry and
Repository on a rare disease of interest to the scientific mission of
the NIAMS. Rare diseases of interest to the NIAMS include rare
rheumatic diseases of adults and children such as childhood lupus and
scleroderma, vasculitides, any of the spondyloarthropathies,
antiphospholipid antibody syndrome, rare bone and muscle diseases of
adults and children such as osteopetrosis and muscular dystrophies,
alopecia areata, ectodermal dysplasia, porphyrias, etc. The purpose of
the Registry and Repository is to collect high quality data and
specimens that will promote and facilitate substantive research
projects, including clinical trials. (2) Technical Objective B is to
design and implement a Research Disease Registry and Repository on a
subset or special population of a common or rare disease(s) of interest
to the NIAMS. Common diseases within the research mission of the NIAMS
include rheumatoid arthritis, fibromyalgia, osteoporosis,
osteoarthritis, psoriasis, inflammatory and allergic skin conditions,
etc. These diseases tend to be heterogenous, and patient subsets or
subpopulations can be identified based on demographic, clinical or
genetic data. Disease evolution, response to treatment and overall
outcomes may vary in these populations, and research objectives could
be best met by the availability of well defined and characterized
patient information and samples. The purpose of the Registry and
Repository is to collect high quality data and specimens that will
promote and facilitate substantive research projects, including
clinical trials. The scientific rationale, relevance and magnitude of
the future research Registry are to be established at the time of the
submission. The Contractor should be U.S. based and only probands
located within the United States should be accepted for entry into the
Registry. It is acceptable, however, to obtain and include information
in the Registry about non-U.S. based family members. Offerors may
submit proposals for Technical Objective A and/or B. It is anticipated
that up to three awards will be made for Technical Objectives A and B
for a period of five years beginning on or about September 30, 2000.
The solicitation NIH-NIAMS-BAA-00-02 will be available electronically
on or about April 20, 2000 and may be accessed through the Internet at
the following address:
http://www.nih.gov/niams/grants/rfp/rfplist.htm. Proposals will be due
on or about June 9, 2000. Offerors are responsible for downloading
their own copy of the solicitation and amendments and for routinely
checking the Internet site for any possible solicitation amendments
that may be issued by the Government. All responsible sources may
submit proposals which will be considered by the Government. This
advertisement does not commit the Government to award a contract.*****
Posted 04/04/00 (W-SN441210). (0095) Loren Data Corp. http://www.ld.com (SYN# 0003 20000406\A-0003.SOL)
A - Research and Development Index Page
|
|